163 related articles for article (PubMed ID: 22391702)
1. The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study.
Wahner-Roedler DL; Boughey JC; Hruska CB; Chen B; Rhodes DJ; Tortorelli CL; Maxwell RW; Cha SS; O'Connor MK
Clin Nucl Med; 2012 Apr; 37(4):344-50. PubMed ID: 22391702
[TBL] [Abstract][Full Text] [Related]
2. Comparison of
Hunt KN; Conners AL; Goetz MP; O'Connor MK; Suman V; Kalari K; Weinshilboum R; Wang L; Carter J; McLaughlin S; Aspitia AM; Gray R; Northfelt D; Boughey JC
AJR Am J Roentgenol; 2019 Oct; 213(4):932-943. PubMed ID: 31166752
[No Abstract] [Full Text] [Related]
3. 99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
Mitchell D; Hruska CB; Boughey JC; Wahner-Roedler DL; Jones KN; Tortorelli C; Conners AL; O'Connor MK
Clin Nucl Med; 2013 Dec; 38(12):949-56. PubMed ID: 24152645
[TBL] [Abstract][Full Text] [Related]
4. Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.
Hruska CB; Weinmann AL; Tello Skjerseth CM; Wagenaar EM; Conners AL; Tortorelli CL; Maxwell RW; Rhodes DJ; O'Connor MK
Med Phys; 2012 Jun; 39(6):3476-83. PubMed ID: 22755727
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.
Menes TS; Golan O; Vainer G; Lerman H; Schneebaum S; Klausner J; Even-Sapir E
Clin Breast Cancer; 2016 Oct; 16(5):389-395. PubMed ID: 27282845
[TBL] [Abstract][Full Text] [Related]
6. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.
Rhodes DJ; O'Connor MK; Phillips SW; Smith RL; Collins DA
Mayo Clin Proc; 2005 Jan; 80(1):24-30. PubMed ID: 15667025
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
8. The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.
Nuvoli S; Galassi S; Gelo I; Rocchitta G; Fancellu A; Serra PA; Madeddu G; Spanu A
Oncol Rep; 2018 May; 39(5):2055-2062. PubMed ID: 29512735
[TBL] [Abstract][Full Text] [Related]
9. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study.
Hruska CB; Hunt KN; Conners AL; Geske JR; Brandt KR; Degnim AC; Vachon CM; O'Connor MK; Rhodes DJ
Breast Cancer Res; 2019 Mar; 21(1):38. PubMed ID: 30850011
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.
Collarino A; Valdés Olmos RA; van Berkel LGAJ; Neijenhuis PA; Wijers LMH; Smit F; de Geus-Oei LF; Pereira Arias-Bouda LM
Breast Cancer Res Treat; 2018 Jun; 169(3):513-522. PubMed ID: 29435855
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi.
Hruska CB; Rhodes DJ; Collins DA; Tortorelli CL; Askew JW; O'Connor MK
J Womens Health (Larchmt); 2012 Jul; 21(7):730-8. PubMed ID: 22404787
[TBL] [Abstract][Full Text] [Related]
12. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
[TBL] [Abstract][Full Text] [Related]
13. Molecular Breast Imaging: A Comprehensive Review.
Huppe AI; Mehta AK; Brem RF
Semin Ultrasound CT MR; 2018 Feb; 39(1):60-69. PubMed ID: 29317040
[TBL] [Abstract][Full Text] [Related]
14. Molecular Breast Imaging in Patients with Suspicious Calcifications.
Hunt KN; Hruska CB; Johnson MP; Conners AL; O'connor MK; Rhodes DJ; Basappa S; Wahner-Roedler D
J Breast Imaging; 2019 Dec; 1(4):303-309. PubMed ID: 38424809
[TBL] [Abstract][Full Text] [Related]
15. Molecular breast imaging.
O'Connor M; Rhodes D; Hruska C
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1073-80. PubMed ID: 19671027
[TBL] [Abstract][Full Text] [Related]
16. PPV of the Molecular Breast Imaging Lexicon.
Hunt KN; Conners AL; Samreen N; Rhodes DJ; Johnson MP; Hruska CB
AJR Am J Roentgenol; 2023 Jan; 220(1):40-48. PubMed ID: 35856455
[No Abstract] [Full Text] [Related]
17. Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.
O'Connor MK; Morrow MMB; Hunt KN; Boughey JC; Wahner-Roedler DL; Conners AL; Rhodes DJ; Hruska CB
EJNMMI Res; 2017 Dec; 7(1):5. PubMed ID: 28091980
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial.
van Egdom LSE; Lagendijk M; Heijkoop EHM; Koning AHJ; van Deurzen CHM; Jager A; van Lankeren W; Koppert LB
Eur J Radiol; 2018 Jul; 104():94-100. PubMed ID: 29857873
[TBL] [Abstract][Full Text] [Related]
19. Collimator design for a dedicated molecular breast imaging-guided biopsy system: proof-of-concept.
Weinmann AL; Hruska CB; Conners AL; O'Connor MK
Med Phys; 2013 Jan; 40(1):012503. PubMed ID: 23298114
[TBL] [Abstract][Full Text] [Related]
20. Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience.
Hruska CB; Boughey JC; Phillips SW; Rhodes DJ; Wahner-Roedler DL; Whaley DH; Degnim AC; O'Connor MK
Am J Surg; 2008 Oct; 196(4):470-6. PubMed ID: 18723155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
